STAT1 and pathogens, not a friendly relationship

Abstract STAT1 belongs to the STAT family of transcription factors, which comprises seven factors: STAT1, STAT2, STAT3, STAT4, STAT5A, STAT5B and STAT6. STAT1 is a 91 kDa protein originally identified as the mediator of the cellular response to interferon (IFN) α, and thereafter found to be a major component of the cellular response to IFNγ. STAT1 is, in fact, involved in the response to several cytokines and to growth factors. It is activated by cytokine receptors via kinases of the JAK family. STAT1 becomes phosphorylated and forms a dimer which enters the nucleus and triggers the transcription of its targets. Although not lethal at birth, selective gene deletion of STAT1 in mice leads to rapid death from severe infections, demonstrating its major role in the response to pathogens. Similarly, in humans who do not express STAT1, there is a lack of resistance to pathogens leading to premature death. This indicates a key, non-redundant function of STAT1 in the defence against pathogens. Thus, to successfully infect organisms, bacterial, viral or parasitic pathogens must overcome the activity of STAT1, and almost all the steps of this pathway can be blocked or inhibited by proteins produced in infected cells. Interestingly, some pathogens, like the oncogenic Epstein–Barr virus, have evolved a strategy which uses STAT1 activation.

[1]  C. Horvath,et al.  Nipah Virus V Protein Evades Alpha and Gamma Interferons by Preventing STAT1 and STAT2 Activation and Nuclear Accumulation , 2002, Journal of Virology.

[2]  B. Groner,et al.  Cooperation Among Stat1, Glucocorticoid Receptor, and PU.1 in Transcriptional Activation of the High-Affinity Fcγ Receptor I in Monocytes1 , 2000, The Journal of Immunology.

[3]  Kevin M. McBride,et al.  Regulated nuclear import of the STAT1 transcription factor by direct binding of importin‐α , 2002, The EMBO journal.

[4]  K. Kawa,et al.  Epstein-Barr virus--associated diseases in humans. , 2000, International journal of hematology.

[5]  A. Satoskar,et al.  Development of protective immunity against cutaneous leishmaniasis is dependent on STAT1‐mediated IFN signaling pathway , 2003, European journal of immunology.

[6]  L. Glimcher,et al.  Cutting Edge: STAT1 and T-bet Play Distinct Roles in Determining Outcome of Visceral Leishmaniasis Caused by Leishmania donovani1 , 2006, The Journal of Immunology.

[7]  E. Haber,et al.  Interferon-γ-mediated Inhibition of Cyclin A Gene Transcription Is Independent of Individual cis-Acting Elements in the Cyclin A Promoter* , 1999, The Journal of Biological Chemistry.

[8]  R. Schreiber,et al.  Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[9]  B. Butcher,et al.  STAT1 Is Essential for Antimicrobial Effector Function but Dispensable for Gamma Interferon Production during Toxoplasma gondii Infection , 2004, Infection and Immunity.

[10]  T. Hirano,et al.  Extracellular signal‐dependent nuclear import of Stat1 is mediated by nuclear pore‐targeting complex formation with NPI‐1, but not Rch1 , 1997, The EMBO journal.

[11]  U. Vinkemeier,et al.  Tyrosine phosphorylation regulates the partitioning of STAT1 between different dimer conformations , 2008, Proceedings of the National Academy of Sciences.

[12]  D. Frank,et al.  STAT1 mediates differentiation of chronic lymphocytic leukemia cells in response to Bryostatin 1. , 2003, Blood.

[13]  P. Najarro,et al.  Vaccinia Virus Blocks Gamma Interferon Signal Transduction: Viral VH1 Phosphatase Reverses Stat1 Activation , 2001, Journal of Virology.

[14]  T. Decker,et al.  GAS elements: a few nucleotides with a major impact on cytokine-induced gene expression. , 1997, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[15]  V. Volchkov,et al.  Nipah Virus Sequesters Inactive STAT1 in the Nucleus via a P Gene-Encoded Mechanism , 2009, Journal of Virology.

[16]  S. Majumder,et al.  p48/STAT-1α-Containing Complexes Play a Predominant Role in Induction of IFN-γ-Inducible Protein, 10 kDa (IP-10) by IFN-γ Alone or in Synergy with TNF-α , 1998, The Journal of Immunology.

[17]  M. Horwitz,et al.  IFN-gamma-activated human alveolar macrophages inhibit the intracellular multiplication of Legionella pneumophila. , 1988, Journal of immunology.

[18]  B. Berk,et al.  Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor , 1995, Nature.

[19]  G. Moseley,et al.  Dual modes of rabies P-protein association with microtubules: a novel strategy to suppress the antiviral response , 2009, Journal of Cell Science.

[20]  J. Ernst,et al.  Mycobacterium tuberculosis Exerts Gene-Selective Inhibition of Transcriptional Responses to IFN-γ Without Inhibiting STAT1 Function1 , 2003, The Journal of Immunology.

[21]  J. H. Pope,et al.  Transformation of foetal human leukocytes in vitro by filtrates of a human leukaemic cell line containing herpes‐like virus , 1968 .

[22]  J. H. Pope,et al.  Establishment of cell lines from Australian leukaemic patients: presence of a herpes-like virus. , 1968, The Australian journal of experimental biology and medical science.

[23]  J. J. Zhang,et al.  Stat1-Dependent Synergistic Activation of T-bet for IgG2a Production during Early Stage of B Cell Activation1 , 2005, The Journal of Immunology.

[24]  L. Young,et al.  Epstein–Barr virus latent membrane protein inhibits human epithelial cell differentiation , 1990, Nature.

[25]  C. Horvath,et al.  STAT proteins and transcriptional responses to extracellular signals. , 2000, Trends in biochemical sciences.

[26]  B. Bauvois,et al.  Interferons inhibit tumor necrosis factor-alpha-mediated matrix metalloproteinase-9 activation via interferon regulatory factor-1 binding competition with NF-kappa B. , 2002, The Journal of biological chemistry.

[27]  David E. Levy,et al.  Distinct Requirements for IFNs and STAT1 in NK Cell Function1 , 2000, The Journal of Immunology.

[28]  W. Bellini,et al.  The C protein of measles virus inhibits the type I interferon response. , 2003, Virology.

[29]  M. Hibberd,et al.  Whole-Genome Expression Profiling Reveals That Inhibition of Host Innate Immune Response Pathways by Ebola Virus Can Be Reversed by a Single Amino Acid Change in the VP35 Protein , 2008, Journal of Virology.

[30]  D. Isenberg,et al.  Signal Transducer and Activator of Transcription-1 and Heat Shock Factor-1 Interact and Activate the Transcription of the Hsp-70 and Hsp-90β Gene Promoters* , 1999, The Journal of Biological Chemistry.

[31]  J. Nair,et al.  B cell antigen receptor signaling enhances IFN-gamma-induced Stat1 target gene expression through calcium mobilization and activation of multiple serine kinase pathways. , 2005, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[32]  S. Jonjić,et al.  Novel Functions of Tyrosine Kinase 2 in the Antiviral Defense against Murine Cytomegalovirus1 , 2005, The Journal of Immunology.

[33]  G. Stark,et al.  Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFkappaB. , 2007, Genes & development.

[34]  Chulhee Choi,et al.  Differential Regulation and Function of Fas Expression on Glial Cells1 , 2000, The Journal of Immunology.

[35]  T. Maniatis,et al.  Multiple Functions of the IKK-Related Kinase IKKε in Interferon-Mediated Antiviral Immunity , 2007, Science.

[36]  R. Knight,et al.  STAT-1 Interacts with p53 to Enhance DNA Damage-induced Apoptosis* , 2004, Journal of Biological Chemistry.

[37]  Dan Yang,et al.  Cooperation of STAT-1 and IRF-1 in interferon-gamma-induced transcription of the gp91(phox) gene. , 2002, The Journal of biological chemistry.

[38]  J. Darnell,et al.  Two distinct alpha-interferon-dependent signal transduction pathways may contribute to activation of transcription of the guanylate-binding protein gene , 1991, Molecular and cellular biology.

[39]  G. Rao,et al.  Thiol alkylation inhibits the mitogenic effects of platelet-derived growth factor and renders it proapoptotic via activation of STATs and p53 and induction of expression of caspase1 and p21waf1/cip1 , 2003, Oncogene.

[40]  Kui Li,et al.  Down-regulation of dendritic cell signaling pathways by Leishmania amazonensis amastigotes. , 2008, Molecular immunology.

[41]  D. Rowe,et al.  Epstein-Barr virus immortalization and latency. , 1999, Frontiers in bioscience : a journal and virtual library.

[42]  Y. Iwakura,et al.  Induction of IgG2a Class Switching in B Cells by IL-271 , 2004, The Journal of Immunology.

[43]  A. García-Sastre,et al.  Type I IFN Modulates Innate and Specific Antiviral Immunity1 , 2000, The Journal of Immunology.

[44]  E. Schmidt,et al.  Hepatitis C virus expression suppresses interferon signaling by degrading STAT1. , 2005, Gastroenterology.

[45]  Yongfang Jiang,et al.  Hepatitis C virus non-structural 5A abrogates signal transducer and activator of transcription-1 nuclear translocation induced by IFN-alpha through dephosphorylation. , 2007, World journal of gastroenterology.

[46]  Soldano Ferrone,et al.  Different Requirements for Signal Transducer and Activator of Transcription 1α and Interferon Regulatory Factor 1 in the Regulation of Low Molecular Mass Polypeptide 2 and Transporter Associated with Antigen Processing 1 Gene Expression* , 1998, The Journal of Biological Chemistry.

[47]  D. Garcin,et al.  All four Sendai Virus C proteins bind Stat1, but only the larger forms also induce its mono-ubiquitination and degradation. , 2002, Virology.

[48]  D. Wesemann,et al.  Erratum: TRADD interacts with STAT1-α and influences interferon-γ signaling , 2004, Nature Immunology.

[49]  Z. Zak,et al.  Interleukin-21 effectively induces apoptosis in mantle cell lymphoma through a STAT1-dependent mechanism , 2009, Leukemia.

[50]  J. Andersen,et al.  Molecular mimicry of a CCR5 binding-domain in the microbial activation of dendritic cells , 2003, Nature Immunology.

[51]  P. Vidalain,et al.  Inhibition of IFN-alpha/beta signaling by two discrete peptides within measles virus V protein that specifically bind STAT1 and STAT2. , 2009, Virology.

[52]  B. Chait,et al.  Ser727‐dependent recruitment of MCM5 by Stat1α in IFN‐γ‐induced transcriptional activation , 1998 .

[53]  A. Verma,et al.  Activation of protein kinase C delta by IFN-gamma. , 2003, Journal of immunology.

[54]  E. Croze,et al.  Reconstitution of a High Affinity Binding Site for Type I Interferons (*) , 1995, The Journal of Biological Chemistry.

[55]  W. Min,et al.  Kinetically coordinated induction of TAP1 and HLA class I by IFN-gamma: the rapid induction of TAP1 by IFN-gamma is mediated by Stat1 alpha. , 1996, Journal of immunology.

[56]  Wei Gu,et al.  Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain , 1997, Cell.

[57]  E. Kieff,et al.  An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells , 1985, Cell.

[58]  E. A. Havell,et al.  Effect of interferon on the growth of Chlamydia trachomatis in mouse fibroblasts (L cells) , 1983, Infection and immunity.

[59]  S. Finke,et al.  Inhibition of Interferon Signaling by Rabies Virus Phosphoprotein P: Activation-Dependent Binding of STAT1 and STAT2 , 2006, Journal of Virology.

[60]  R. Schreiber,et al.  Targeted Disruption of the Stat1 Gene in Mice Reveals Unexpected Physiologic Specificity in the JAK–STAT Signaling Pathway , 1996, Cell.

[61]  K. Honda,et al.  IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors , 2006, Nature Reviews Immunology.

[62]  O. Colamonici,et al.  p135tyk2, an interferon-alpha-activated tyrosine kinase, is physically associated with an interferon-alpha receptor. , 1994, The Journal of biological chemistry.

[63]  W. Rom,et al.  Differentiation of Monocytes to Macrophages Switches the Mycobacterium tuberculosis Effect on HIV-1 Replication from Stimulation to Inhibition: Modulation of Interferon Response and CCAAT/Enhancer Binding Protein β Expression1 , 2000, The Journal of Immunology.

[64]  D. Wesemann,et al.  TRADD interacts with STAT1-α and influences interferon-γ signaling , 2004, Nature Immunology.

[65]  M. Ueffing,et al.  Latent membrane protein 1 of Epstein–Barr virus mimics a constitutively active receptor molecule , 1997, The EMBO journal.

[66]  David E Levy,et al.  STAT1 acts as a tumor promoter for leukemia development. , 2006, Cancer cell.

[67]  P. Bucher,et al.  DNA Binding Specificity of Different STAT Proteins , 2001, The Journal of Biological Chemistry.

[68]  F. Baran-Marszak,et al.  Differential roles of STAT1alpha and STAT1beta in fludarabine-induced cell cycle arrest and apoptosis in human B cells. , 2004, Blood.

[69]  I. Dusanter-Fourt,et al.  STAT1‐dependent IgG cell‐surface expression in a human B cell line derived from a STAT1‐deficient patient , 2010, Journal of leukocyte biology.

[70]  M. Baron,et al.  Inhibition of IFN-gamma-induced STAT1 tyrosine phosphorylation by human CMV is mediated by SHP2. , 2008, Journal of immunology.

[71]  C. Horvath,et al.  Hendra Virus V Protein Inhibits Interferon Signaling by Preventing STAT1 and STAT2 Nuclear Accumulation , 2003, Journal of Virology.

[72]  H. Murray,et al.  Gamma-interferon is the factor in lymphokine that activates human macrophages to inhibit intracellular Chlamydia psittaci replication. , 1983, Journal of immunology.

[73]  C. Ware,et al.  The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family , 1995, Cell.

[74]  I. Lödige,et al.  Nuclear Export Determines the Cytokine Sensitivity of STAT Transcription Factors* , 2005, Journal of Biological Chemistry.

[75]  T. Hoey,et al.  Cooperative DNA Binding and Sequence-Selective Recognition Conferred by the STAT Amino-Terminal Domain , 1996, Science.

[76]  A. Larner,et al.  The Jak kinases differentially associate with the alpha and beta (accessory factor) chains of the interferon gamma receptor to form a functional receptor unit capable of activating STAT transcription factors. , 1995, The Journal of biological chemistry.

[77]  A. Verma,et al.  Protein Kinase C-δ (PKC-δ) Is Activated by Type I Interferons and Mediates Phosphorylation of Stat1 on Serine 727* , 2002, The Journal of Biological Chemistry.

[78]  J. Casanova,et al.  Novel STAT1 Alleles in Otherwise Healthy Patients with Mycobacterial Disease , 2006, PLoS genetics.

[79]  G. Stark,et al.  How Stat1 mediates constitutive gene expression: a complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 gene , 2000, The EMBO journal.

[80]  P. Vidalain,et al.  Measles virus V protein blocks Jak1-mediated phosphorylation of STAT1 to escape IFN-alpha/beta signaling. , 2007, Virology.

[81]  B. Williams,et al.  Identification and characterization of an interferon (IFN)-stimulated response element-IFN-stimulated gene factor 3-independent signaling pathway for IFN-α , 1994 .

[82]  Ralph S. Baric,et al.  Severe Acute Respiratory Syndrome Coronavirus ORF6 Antagonizes STAT1 Function by Sequestering Nuclear Import Factors on the Rough Endoplasmic Reticulum/Golgi Membrane , 2007, Journal of Virology.

[83]  C. Brosnan,et al.  15-Deoxy-Δ12,14-Prostaglandin J2 Inhibits IFN-Inducible Protein 10/CXC Chemokine Ligand 10 Expression in Human Microglia: Mechanisms and Implications1 , 2004, The Journal of Immunology.

[84]  J. Darnell,et al.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. , 1994, Science.

[85]  T. Ide,et al.  Reconsideration of senescence, immortalization and telomere maintenance of Epstein–Barr virus-transformed human B-lymphoblastoid cell lines , 1999, Mechanisms of Ageing and Development.

[86]  Judith P. Johnson,et al.  Intercellular Adhesion Molecule 1 (ICAM-1) is Synergistically Activated by TNF-α and IFN-γ Responsive Sites , 1995 .

[87]  J. Casanova,et al.  A partial form of recessive STAT1 deficiency in humans. , 2009, The Journal of clinical investigation.

[88]  D. Latchman,et al.  Opposing actions of STAT-1 and STAT-3 on the Bcl-2 and Bcl-x promoters , 2000, Cell Death and Differentiation.

[89]  L. Young,et al.  LMP1 structure and signal transduction. , 2001, Seminars in cancer biology.

[90]  J. Darnell,et al.  Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[91]  M. Hidalgo,et al.  Progress in the development and acquisition of anticancer agents from marine sources. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[92]  J. Johnson,et al.  Intercellular adhesion molecule 1 (ICAM-1) is synergistically activated by TNF-alpha and IFN-gamma responsive sites. , 1995, Immunobiology.

[93]  J. Darnell,et al.  Cytoplasmic activation of ISGF3, the positive regulator of interferon-alpha-stimulated transcription, reconstituted in vitro. , 1989, Genes & development.

[94]  N. Ling,et al.  A phenotypic study of cells from burkitt lymphoma and ebv‐b‐lymphoblastoid lines and their relationship to cells in normal lymphoid tissues , 1989, International journal of cancer.

[95]  B. Lemon,et al.  The dual-specificity phosphatase encoded by vaccinia virus, VH1, is essential for viral transcription in vivo and in vitro , 1995, Journal of virology.

[96]  H. Strander,et al.  Characterization of ebv‐carrying b‐cell populations in healthy seropositive individuals with regard to density, release of transforming virus and spontaneous outgrowth , 1987, International journal of cancer.

[97]  G. Stark,et al.  Unphosphorylated STAT1 prolongs the expression of interferon-induced immune regulatory genes , 2009, Proceedings of the National Academy of Sciences.

[98]  U. Bauer,et al.  PRMT1-mediated arginine methylation of PIAS1 regulates STAT1 signaling. , 2009, Genes & development.

[99]  R. Schreiber,et al.  A Novel c-Jun-dependent Signal Transduction Pathway Necessary for the Transcriptional Activation of Interferon γ Response Genes* , 2007, Journal of Biological Chemistry.

[100]  M. Olivier,et al.  Role of Host Protein Tyrosine Phosphatase SHP-1 in Leishmania donovani-Induced Inhibition of Nitric Oxide Production , 2006, Infection and Immunity.

[101]  D. Levy,et al.  Stat2 Is a Transcriptional Activator That Requires Sequence-specific Contacts Provided by Stat1 and p48 for Stable Interaction with DNA* , 1997, The Journal of Biological Chemistry.

[102]  J. Darnell,et al.  Two contact regions between Stat1 and CBP/p300 in interferon gamma signaling. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[103]  C. Ni,et al.  LMP1 Protein from the Epstein-Barr Virus Is a Structural CD40 Decoy in B Lymphocytes for Binding to TRAF3* , 2005, Journal of Biological Chemistry.

[104]  C. Horvath Weapons of STAT destruction , 2004 .

[105]  M. Tsurudome,et al.  High Resistance of Human Parainfluenza Type 2 Virus Protein-Expressing Cells to the Antiviral and Anti-Cell Proliferative Activities of Alpha/Beta Interferons: Cysteine-Rich V-Specific Domain Is Required for High Resistance to the Interferons , 2001, Journal of Virology.

[106]  G. Stark,et al.  Stat1-Dependent, p53-Independent Expression of p21waf1 Modulates Oxysterol-Induced Apoptosis , 2002, Molecular and Cellular Biology.

[107]  J. J. Zhang,et al.  Identification of two residues in MCM5 critical for the assembly of MCM complexes and Stat1-mediated transcription activation in response to IFN-γ , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[108]  A. Verma,et al.  Protein kinase C-delta (PKC-delta ) is activated by type I interferons and mediates phosphorylation of Stat1 on serine 727. , 2002, The Journal of biological chemistry.

[109]  M. David,et al.  Arginine methylation of STAT1 modulates IFNalpha/beta-induced transcription. , 2001, Cell.

[110]  G. Klein,et al.  EBV‐transformed lymphoblastoid cell lines down‐regulate ebna in parallel with secretory differentiation , 1987, International journal of cancer.

[111]  J. Darnell,et al.  The antiviral state induced by alpha interferon and gamma interferon requires transcriptionally active Stat1 protein , 1996, Journal of virology.

[112]  V. Volchkov,et al.  Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation. , 2006, Journal of virology.

[113]  V. Gouilleux-Gruart,et al.  Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines. , 1996, Blood.

[114]  M. Rowe,et al.  Mechanism of Action of a Novel Latent Membrane Protein-1 Dominant Negative* , 2001, The Journal of Biological Chemistry.

[115]  M. Rowe,et al.  Latent Membrane Protein 1 of Epstein-Barr Virus Stimulates Processing of NF-κB2 p100 to p52* , 2003, Journal of Biological Chemistry.

[116]  S. Akira,et al.  Elucidation of the c-Jun N-Terminal Kinase Pathway Mediated by Epstein-Barr Virus-Encoded Latent Membrane Protein 1 , 2004, Molecular and Cellular Biology.

[117]  A. Polack,et al.  Inducible loss of NF-kappaB activity is associated with apoptosis and Bcl-2 down-regulation in Epstein-Barr virus-transformed B lymphocytes. , 2000, Blood.

[118]  L. Pfeffer,et al.  Induction of Jak/STAT signaling by activation of the type 1 TNF receptor. , 1998, Journal of immunology.

[119]  N. Reiner,et al.  Attenuation of gamma interferon-induced tyrosine phosphorylation in mononuclear phagocytes infected with Leishmania donovani: selective inhibition of signaling through Janus kinases and Stat1 , 1995, Infection and immunity.

[120]  S. Zaki,et al.  Inhibition of IRF-3 Activation by VP35 Is Critical for the High Level of Virulence of Ebola Virus , 2008, Journal of Virology.

[121]  S. Krishnamurthy,et al.  Newcastle Disease Virus V Protein Is Associated with Viral Pathogenesis and Functions as an Alpha Interferon Antagonist , 2003, Journal of Virology.

[122]  Edward W Scott,et al.  Distinct functions for signal transducer and activator of transcription 1 and PU.1 in transcriptional activation of Fc gamma receptor I promoter. , 2002, Blood.

[123]  D. Thorley-Lawson,et al.  EBV persistence in memory B cells in vivo. , 1998, Immunity.

[124]  B. Zwilling,et al.  Mycobacterium avium Inhibition of IFN-γ Signaling in Mouse Macrophages: Toll-Like Receptor 2 Stimulation Increases Expression of Dominant-Negative STAT1β by mRNA Stabilization 1 , 2003, The Journal of Immunology.

[125]  B. Chait,et al.  Ser727-dependent recruitment of MCM5 by Stat1alpha in IFN-gamma-induced transcriptional activation. , 1998, The EMBO journal.

[126]  D. Goeddel,et al.  Interferon-gamma induces receptor dimerization in solution and on cells. , 1993, The Journal of biological chemistry.

[127]  T. Kishimoto IL-6 , 2005 .

[128]  A. Levine,et al.  The p53 pathway: positive and negative feedback loops , 2005, Oncogene.

[129]  R. Kraft,et al.  Two different subunits of importin cooperate to recognize nuclear localization signals and bind them to the nuclear envelope , 1995, Current Biology.

[130]  I. Lödige,et al.  Constitutive and IFN‐γ‐induced nuclear import of STAT1 proceed through independent pathways , 2002 .

[131]  T. Taniguchi,et al.  Stat1 functions as a cytoplasmic attenuator of Runx2 in the transcriptional program of osteoblast differentiation. , 2003, Genes & development.

[132]  G. Lesinski,et al.  The antitumor effects of IFN-α are abrogated in a STAT1-deficient mouse , 2003 .

[133]  D. Wesemann,et al.  TRADD interacts with STAT1-alpha and influences interferon-gamma signaling. , 2004, Nature immunology.

[134]  A. Aggarwal,et al.  Structure of IRF-1 with bound DNA reveals determinants of interferon regulation , 1998, Nature.

[135]  Mutsuko Ouchi,et al.  Collaboration of signal transducer and activator of transcription 1 (STAT1) and BRCA1 in differential regulation of IFN-gamma target genes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[136]  Karsten Weis,et al.  Exportin 1 (Crm1p) Is an Essential Nuclear Export Factor , 1997, Cell.

[137]  P. Hersey,et al.  Interferon-resistant Human Melanoma Cells Are Deficient in ISGF3 Components, STAT1, STAT2, and p48-ISGF3γ* , 1997, The Journal of Biological Chemistry.

[138]  F. Baran-Marszak,et al.  Latent Membrane Protein 1 Regulates STAT1 through NF-κB-Dependent Interferon Secretion in Epstein-Barr Virus-Immortalized B Cells , 2005, Journal of Virology.

[139]  David P Lane,et al.  A novel CDK inhibitor, CYC202 (R-roscovitine), overcomes the defect in p53-dependent apoptosis in B-CLL by down-regulation of genes involved in transcription regulation and survival. , 2005, Blood.

[140]  S. Smirnov,et al.  Cutting Edge: IL-26 Signals through a Novel Receptor Complex Composed of IL-20 Receptor 1 and IL-10 Receptor 2 1 , 2004, The Journal of Immunology.

[141]  E. May,et al.  Identification of a novel p53-dependent activation pathway of STAT1 by antitumour genotoxic agents , 2008, Cell Death and Differentiation.

[142]  P. Pitha,et al.  The IRF family, revisited. , 2007, Biochimie.

[143]  M. Ohtsubo,et al.  Interruption of NFκb–stat1 signaling mediates EGF‐induced cell‐cycle arrest , 2000 .

[144]  L. Young,et al.  Differences in B cell growth phenotype reflect novel patterns of Epstein‐Barr virus latent gene expression in Burkitt's lymphoma cells. , 1987, The EMBO journal.

[145]  K. Wright,et al.  Loss of interferon-gamma inducibility of TAP1 and LMP2 in a renal cell carcinoma cell line. , 2000, Cancer research.

[146]  C. Horvath Weapons of STAT destruction. Interferon evasion by paramyxovirus V protein. , 2004, European journal of biochemistry.

[147]  M. Rowe,et al.  Epstein-Barr virus induces a distinct form of DNA-bound STAT1 compared with that found in interferon-stimulated B lymphocytes. , 2007, The Journal of general virology.

[148]  D. Rowe,et al.  Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes , 1992, Journal of virology.

[149]  K. Shuai,et al.  Disease-activated transcription factor: allergic reactions in human skin cause nuclear translocation of STAT-91 and induce synthesis of keratin K17 , 1994, Molecular and cellular biology.

[150]  J. Darnell,et al.  Dephosphorylation of phosphotyrosine on STAT1 dimers requires extensive spatial reorientation of the monomers facilitated by the N-terminal domain. , 2006, Genes & development.

[151]  U. Vinkemeier,et al.  Constitutive and IFN-gamma-induced nuclear import of STAT1 proceed through independent pathways. , 2002, The EMBO journal.

[152]  G. Blobel,et al.  The binding site of karyopherin alpha for karyopherin beta overlaps with a nuclear localization sequence. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[153]  B. Cohen,et al.  Ligand-induced association of the type I interferon receptor components , 1995, Molecular and cellular biology.

[154]  David E. Levy,et al.  STAT1 Affects Lymphocyte Survival and Proliferation Partially Independent of Its Role Downstream of IFN-γ1 , 2000, The Journal of Immunology.

[155]  C. Schindler,et al.  Amino-terminal Signal Transducer and Activator of Transcription (STAT) Domains Regulate Nuclear Translocation and STAT Deactivation* , 1998, The Journal of Biological Chemistry.

[156]  J. Pagano,et al.  Multiple signal transducers and activators of transcription are induced by EBV LMP-1. , 2004, Virology.

[157]  P. Subramaniam,et al.  So many ligands, so few transcription factors: a new paradigm for signaling through the STAT transcription factors. , 2001, Cytokine.

[158]  Miss A.O. Penney (b) , 1974, The New Yale Book of Quotations.

[159]  Ren-Jye Lin,et al.  Blocking of Interferon-Induced Jak-Stat Signaling by Japanese Encephalitis Virus NS5 through a Protein Tyrosine Phosphatase-Mediated Mechanism , 2006, Journal of Virology.

[160]  J. Johnson,et al.  Synergistic activation of intercellular adhesion molecule 1 (ICAM-1) by TNF-alpha and IFN-gamma is mediated by p65/p50 and p65/c-Rel and interferon-responsive factor Stat1 alpha (p91) that can be activated by both IFN-gamma and IFN-alpha. , 1994, FEBS letters.

[161]  V. Lafont,et al.  The IFNgamma-induced STAT1-CBP/P300 association, required for a normal response to the cytokine, is disrupted in Brucella-infected macrophages. , 2009, Microbial pathogenesis.

[162]  L. Young,et al.  The Epstein-Barr virus carrier state: dominance of a single growth-transforming isolate in the blood and in the oropharynx of healthy virus carriers. , 1991, The Journal of general virology.

[163]  M. Ueffing,et al.  Latent membrane protein 1 of Epstein–Barr virus interacts with JAK3 and activates STAT proteins , 1999, The EMBO journal.

[164]  M. Epstein,et al.  A re‐examination of the epstein‐barr virus carrier state in healthy seropositive individuals , 1985, International journal of cancer.

[165]  A. Verma,et al.  Activation of Protein Kinase Cδ by IFN-γ1 , 2003, The Journal of Immunology.

[166]  R. Schreiber,et al.  Stat recruitment by tyrosine-phosphorylated cytokine receptors: an ordered reversible affinity-driven process. , 1995, Immunity.

[167]  R. Aebersold,et al.  Proteins of transcription factor ISGF-3: one gene encodes the 91-and 84-kDa ISGF-3 proteins that are activated by interferon alpha. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[168]  B. Williams,et al.  Identification and characterization of an interferon (IFN)-stimulated response element-IFN-stimulated gene factor 3-independent signaling pathway for IFN-alpha. , 1994, The Journal of biological chemistry.

[169]  Xiaomin Chen,et al.  Crystallization and X-ray crystallographic analysis of human STAT1. , 2005, Acta crystallographica. Section F, Structural biology and crystallization communications.

[170]  J. ten Hoeve,et al.  Identification of a Nuclear Stat1 Protein Tyrosine Phosphatase , 2002, Molecular and Cellular Biology.

[171]  B. Bauvois,et al.  Interferons Inhibit Tumor Necrosis Factor-α-mediated Matrix Metalloproteinase-9 Activation via Interferon Regulatory Factor-1 Binding Competition with NF-κB* , 2002, The Journal of Biological Chemistry.

[172]  U. Vinkemeier,et al.  Cell type-specific and tyrosine phosphorylation-independent nuclear presence of STAT1 and STAT3. , 2002, Experimental cell research.

[173]  Andreas Marg,et al.  DNA binding controls inactivation and nuclear accumulation of the transcription factor Stat1. , 2003, Genes & development.

[174]  J. Darnell,et al.  Distinct transcriptional activation functions of STAT1alpha and STAT1beta on DNA and chromatin templates. , 2003, The Journal of biological chemistry.

[175]  R. Knight,et al.  Ischemia-induced STAT-1 Expression and Activation Play a Critical Role in Cardiomyocyte Apoptosis* , 2000, The Journal of Biological Chemistry.

[176]  K. Nilsson,et al.  Ser727/Tyr701-phosphorylated Stat1 is required for the regulation of c-Myc, cyclins, and p27Kip1 associated with ATRA-induced G0/G1 arrest of U-937 cells. , 2003, Blood.

[177]  M. Ohtsubo,et al.  Interruption of NFkappaB-STAT1 signaling mediates EGF-induced cell-cycle arrest. , 2000, Journal of cellular physiology.

[178]  C. Paulus,et al.  A human cytomegalovirus antagonist of type I IFN-dependent signal transducer and activator of transcription signaling. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[179]  I. Macara,et al.  Requirement of guanosine triphosphate-bound ran for signal-mediated nuclear protein export. , 1997, Science.

[180]  J. Darnell,et al.  Crystal Structure of a Tyrosine Phosphorylated STAT-1 Dimer Bound to DNA , 1998, Cell.

[181]  J. Darnell,et al.  Function of Stat2 protein in transcriptional activation by alpha interferon , 1996, Molecular and cellular biology.

[182]  F. Espinasse-Maes,et al.  Role of gamma interferon and tumor necrosis factor alpha in resistance to Salmonella typhimurium infection , 1992, Infection and immunity.

[183]  G. Stark,et al.  How cells respond to interferons. , 1998, Annual review of biochemistry.

[184]  E. Petricoin,et al.  Requirement for MAP kinase (ERK2) activity in interferon alpha- and interferon beta-stimulated gene expression through STAT proteins. , 1995, Science.

[185]  C. Marth,et al.  Prognostic significance of signal transducer and activator of transcription 1 activation in breast cancer. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[186]  C. Woodman,et al.  The EBV-encoded Latent Membrane Proteins, LMP2A and LMP2B, Limit the Actions of Interferon by Targeting Interferon Receptors for Degradation , 2009, Oncogene.

[187]  D. Levy,et al.  Specificity of signaling by STAT1 depends on SH2 and C‐terminal domains that regulate Ser727 phosphorylation, differentially affecting specific target gene expression , 2001, The EMBO journal.

[188]  H. Asao,et al.  Cutting Edge: The Common γ-Chain Is an Indispensable Subunit of the IL-21 Receptor Complex1 , 2001, The Journal of Immunology.

[189]  J. Darnell,et al.  Structural bases of unphosphorylated STAT1 association and receptor binding. , 2005, Molecular cell.

[190]  S. Bhattacharya,et al.  Cooperation of Stat2 and p300/CBP in signalling induced by interferon-α , 1996, Nature.

[191]  D. Meyer,et al.  The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH. , 1996, Molecular endocrinology.

[192]  R. Schreiber,et al.  Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice , 1998 .

[193]  L. Kinnunen,et al.  Arginine/Lysine-rich Nuclear Localization Signals Mediate Interactions between Dimeric STATs and Importin α5* , 2002, The Journal of Biological Chemistry.

[194]  M. Nassal,et al.  Inhibition of Alpha Interferon Signaling by Hepatitis B Virus , 2006, Journal of Virology.

[195]  Jennifer Y. Zhang,et al.  Innate Inhibition of Adaptive Immunity: Mycobacterium tuberculosis-Induced IL-6 Inhibits Macrophage Responses to IFN-γ 1 , 2003, The Journal of Immunology.

[196]  Carol D. Laherty,et al.  The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kappa B. , 1992, The Journal of biological chemistry.

[197]  L. Palmqvist,et al.  An ATF/CRE Element Mediates both EBNA2-Dependent and EBNA2-Independent Activation of the Epstein-Barr Virus LMP1 Gene Promoter , 1998, Journal of Virology.

[198]  G. G. Stokes "J." , 1890, The New Yale Book of Quotations.

[199]  T. Taniguchi,et al.  Stat1‐mediated cytoplasmic attenuation in osteoimmunology , 2005, Journal of cellular biochemistry.

[200]  Dwight C. Look,et al.  Stat1 Depends on Transcriptional Synergy with Sp1 (*) , 1995, The Journal of Biological Chemistry.

[201]  A. Koromilas,et al.  Stat1 is an inhibitor of Ras-MAPK signaling and Rho small GTPase expression with implications in the transcriptional signature of Ras transformed cells , 2009, Cell cycle.

[202]  B. Wiedenmann,et al.  Interferon‐α delays S‐phase progression in human hepatocellular carcinoma cells via inhibition of specific cyclin‐dependent kinases , 2001 .

[203]  K. Suk,et al.  Interferon gamma (IFNgamma ) and tumor necrosis factor alpha synergism in ME-180 cervical cancer cell apoptosis and necrosis. IFNgamma inhibits cytoprotective NF-kappa B through STAT1/IRF-1 pathways. , 2001, The Journal of biological chemistry.

[204]  S. Goodbourn,et al.  A single amino acid substitution in the V protein of Nipah virus alters its ability to block interferon signalling in cells from different species , 2006, The Journal of general virology.

[205]  Ohira,et al.  Crystallographic Characterization of the DNA-Binding Domain of Interferon Regulatory Factor-2 Complexed with DNA. , 1998, Journal of structural biology.

[206]  D. Dinwiddie,et al.  Human metapneumovirus inhibits IFN-alpha signaling through inhibition of STAT1 phosphorylation. , 2008, American journal of respiratory cell and molecular biology.

[207]  T. Wright,et al.  IFN-gamma induces a p91/Stat1 alpha-related transcription factor with distinct activation and binding properties. , 1995, Journal of immunology.

[208]  Aseem Kumar,et al.  Defective TNF-α-Induced Apoptosis in STAT1-Null Cells Due to Low Constitutive Levels of Caspases , 1997 .

[209]  K. Schroder,et al.  Interferon- : an overview of signals, mechanisms and functions , 2004 .

[210]  P. Fitzpatrick,et al.  Interferon-γ Modulates a p53-independent Apoptotic Pathway and Apoptosis-related Gene Expression* , 1997, The Journal of Biological Chemistry.

[211]  M. Hubank,et al.  STAT-1 facilitates the ATM activated checkpoint pathway following DNA damage , 2005, Journal of Cell Science.

[212]  E. Coutinho,et al.  The amino-terminal domain of human signal transducers and activators of transcription 1: Overexpression, purification and characterization , 2005, Journal of Biosciences.

[213]  K. Heeg,et al.  Induction of Suppressor of Cytokine Signaling-1 by Toxoplasma gondii Contributes to Immune Evasion in Macrophages by Blocking IFN-γ Signaling1 , 2006, The Journal of Immunology.

[214]  M. Borowitz,et al.  Linkage between STAT Regulation and Epstein-Barr Virus Gene Expression in Tumors , 2001, Journal of Virology.

[215]  R. Schreiber,et al.  Ligand-induced assembly and activation of the gamma interferon receptor in intact cells , 1996, Molecular and cellular biology.

[216]  M. Ray,et al.  Inhibition of Interferon-γ Signaling by Leishmania donovani , 2000 .

[217]  M. Rowe,et al.  The bfl-1 Gene Is Transcriptionally Upregulated by the Epstein-Barr Virus LMP1, and Its Expression Promotes the Survival of a Burkitt's Lymphoma Cell Line , 2000, Journal of Virology.

[218]  V. Volchkov,et al.  Ebolavirus VP24 Binding to Karyopherins Is Required for Inhibition of Interferon Signaling , 2009, Journal of Virology.

[219]  J E Darnell,et al.  Epidermal growth factor-induced growth inhibition requires Stat1 activation. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[220]  M. Baron,et al.  Inhibition of IFN-γ-Induced STAT1 Tyrosine Phosphorylation by Human CMV Is Mediated by SHP21 , 2008, The Journal of Immunology.

[221]  K. Nilsson,et al.  Ser 727 / Tyr 701-phosphorylated Stat 1 is required for the regulation of c-Myc , cyclins , and p 27 Kip 1 associated with ATRA-induced G 0 / G 1 arrest of U-937 cells , 2003 .

[222]  D. Isenberg,et al.  Signal transducer and activator of transcription-1 and heat shock factor-1 interact and activate the transcription of the Hsp-70 and Hsp-90beta gene promoters. , 1999, The Journal of biological chemistry.

[223]  C. Horvath,et al.  Paramyxoviruses SV5 and HPIV2 assemble STAT protein ubiquitin ligase complexes from cellular components. , 2002, Virology.

[224]  E. Hartmann,et al.  A 41 amino acid motif in importin‐alpha confers binding to importin‐beta and hence transit into the nucleus. , 1996, The EMBO journal.

[225]  Myung-Shik Lee,et al.  Essential Role of STAT1 in Caspase-Independent Cell Death of Activated Macrophages through the p38 Mitogen-Activated Protein Kinase/STAT1/Reactive Oxygen Species Pathway , 2005, Molecular and Cellular Biology.

[226]  E. Kieff,et al.  The Epstein–Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-κB , 1997 .

[227]  Kevin M. McBride,et al.  Nuclear export signal located within the DNA‐binding domain of the STAT1transcription factor , 2000, The EMBO journal.

[228]  S. Pestka,et al.  Interaction between the Components of the Interferon γ Receptor Complex (*) , 1995, The Journal of Biological Chemistry.

[229]  F. Chang,et al.  HCV NS5A inhibits interferon-alpha signaling through suppression of STAT1 phosphorylation in hepatocyte-derived cell lines. , 2007, Journal of hepatology.

[230]  T. Hunter,et al.  JAK2, Ras, and Raf Are Required for Activation of Extracellular Signal-regulated Kinase/Mitogen-activated Protein Kinase by Growth Hormone (*) , 1995, The Journal of Biological Chemistry.

[231]  Mark Gerstein,et al.  Global changes in STAT target selection and transcription regulation upon interferon treatments. , 2005, Genes & development.

[232]  J. Darnell,et al.  Overlapping elements in the guanylate-binding protein gene promoter mediate transcriptional induction by alpha and gamma interferons , 1991, Molecular and cellular biology.

[233]  T. Maniatis,et al.  Multiple functions of the IKK-related kinase IKKepsilon in interferon-mediated antiviral immunity. , 2007, Science.

[234]  A. Satoskar,et al.  Signal transducer and activator of transcription 1 in T cells plays an indispensable role in immunity to Leishmania major by mediating Th1 cell homing to the site of infection , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[235]  M. Rowe,et al.  Latent membrane protein 1 of Epstein-Barr virus stimulates processing of NF-kappa B2 p100 to p52. , 2003, The Journal of biological chemistry.

[236]  J. Boothroyd,et al.  Toxoplasma gondii Dysregulates IFN-γ-Inducible Gene Expression in Human Fibroblasts: Insights from a Genome-Wide Transcriptional Profiling1 , 2007, The Journal of Immunology.

[237]  J. Darnell,et al.  Distinct Transcriptional Activation Functions of STAT1α and STAT1β on DNA and Chromatin Templates* , 2003, Journal of Biological Chemistry.

[238]  Yoshihiro Ohmori,et al.  Synergy between Interferon-γ and Tumor Necrosis Factor-α in Transcriptional Activation Is Mediated by Cooperation between Signal Transducer and Activator of Transcription 1 and Nuclear Factor κB* , 1997, The Journal of Biological Chemistry.

[239]  Francesco Novelli,et al.  Ups and downs: the STAT1:STAT3 seesaw of Interferon and gp130 receptor signalling. , 2008, Seminars in cell & developmental biology.

[240]  A. Satoskar,et al.  Leishmania inhibits STAT1-mediated IFN-γ signaling in macrophages: increased tyrosine phosphorylation of dominant negative STAT1β by Leishmania mexicana , 2005 .

[241]  R. Schreiber,et al.  Identification of an Interferon- Receptor Chain Sequence Required for JAK-1 Binding (*) , 1996, The Journal of Biological Chemistry.

[242]  K. Pfeffer,et al.  Phosphorylation of the Stat1 transactivation domain is required for full-fledged IFN-gamma-dependent innate immunity. , 2003, Immunity.

[243]  Jonghwan Kim,et al.  Mapping the chromosomal targets of STAT1 by Sequence Tag Analysis of Genomic Enrichment (STAGE). , 2007, Genome research.

[244]  T. Kubota,et al.  C-Terminal Region of STAT-1α Is Not Necessary for Its Ubiquitination and Degradation Caused by Mumps Virus V Protein , 2002, Journal of Virology.

[245]  G R Stark,et al.  Regulation of c-myc expression by IFN-gamma through Stat1-dependent and -independent pathways. , 2000, The EMBO journal.

[246]  E. Scott,et al.  Molecular basis of Stat1 and PU.1 cooperation in cytokine-induced Fcgamma receptor I promoter activation. , 2004, International immunology.

[247]  E. Denkers From cells to signaling cascades: manipulation of innate immunity by Toxoplasma gondii. , 2003, FEMS immunology and medical microbiology.

[248]  A. Zimmermann,et al.  Human cytomegalovirus interferes with signal transducer and activator of transcription (STAT) 2 protein stability and tyrosine phosphorylation. , 2008, The Journal of general virology.

[249]  A. Chong,et al.  IFN-gamma induces cell growth inhibition by Fas-mediated apoptosis: requirement of STAT1 protein for up-regulation of Fas and FasL expression. , 1998, Cancer research.

[250]  D. Blondel,et al.  Rabies Virus P Protein Interacts with STAT1 and Inhibits Interferon Signal Transduction Pathways , 2005, Journal of Virology.

[251]  P. Heinrich,et al.  Are STATS Arginine-methylated?* , 2005, Journal of Biological Chemistry.

[252]  Frédéric Tangy,et al.  Measles virus V protein blocks Jak1-mediated phosphorylation of STAT1 to escape IFN-α/β signaling , 2007 .

[253]  George Stark,et al.  Isolation and Characterization of a Human STAT1Gene Regulatory Element , 2002, The Journal of Biological Chemistry.

[254]  Wei Zhu,et al.  Arginine Methylation of STAT1 Modulates IFNα/β-Induced Transcription , 2001, Cell.

[255]  K. Wright,et al.  Loss of Interferon-γ Inducibility of TAP1 and LMP2 in a Renal Cell Carcinoma Cell Line , 2000 .

[256]  J. Ihle The Stat family in cytokine signaling. , 2001, Current opinion in cell biology.

[257]  B. Chait,et al.  DNA binding of in vitro activated Stat1 alpha, Stat1 beta and truncated Stat1: interaction between NH2‐terminal domains stabilizes binding of two dimers to tandem DNA sites. , 1996, The EMBO journal.

[258]  D. Blondel,et al.  The Nucleocytoplasmic Rabies Virus P Protein Counteracts Interferon Signaling by Inhibiting both Nuclear Accumulation and DNA Binding of STAT1 , 2007, Journal of Virology.

[259]  U. Vinkemeier,et al.  STAT nuclear translocation: potential for pharmacological intervention , 2007, Expert opinion on therapeutic targets.

[260]  L. Ivashkiv,et al.  The Conserved Leu-724 Residue Is Required for Both Serine Phosphorylation and Co-activator Recruitment for Stat1-mediated Transcription Activation in Response to Interferon-γ* , 2005, Journal of Biological Chemistry.

[261]  J. Ritz,et al.  Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signaling , 1999, Nature Medicine.

[262]  E. Kieff,et al.  Epstein–Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKKα-dependent noncanonical NF-κB activation , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[263]  R. Weichselbaum,et al.  STAT1-dependent expression of energy metabolic pathways links tumour growth and radioresistance to the Warburg effect , 2009, BMC medicine.

[264]  J. Darnell,et al.  Contribution of STAT SH2 groups to specific interferon signaling by the Jak-STAT pathway , 1995, Science.

[265]  E. Kieff,et al.  The Epstein-Barr Virus Oncoprotein Latent Membrane Protein 1 Engages the Tumor Necrosis Factor Receptor-Associated Proteins TRADD and Receptor-Interacting Protein (RIP) but Does Not Induce Apoptosis or Require RIP for NF-κB Activation , 1999, Molecular and Cellular Biology.

[266]  G. Klein,et al.  Morphological transformation of human keratinocytes expressing the LMP gene of Epstein Barr virus , 1990, Nature.

[267]  G. Stark,et al.  Rapid activation by interferon alpha of a latent DNA-binding protein present in the cytoplasm of untreated cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[268]  B. Barlogie,et al.  Fludarabine: a new agent with major activity against chronic lymphocytic leukemia. , 1989, Blood.

[269]  K. Chébli,et al.  Translation initiation at alternate in-frame AUG codons in the rabies virus phosphoprotein mRNA is mediated by a ribosomal leaky scanning mechanism , 1995, Journal of virology.

[270]  E. Kieff,et al.  The Epstein-Barr Virus Latent Membrane Protein 1 Putative Janus Kinase 3 (JAK3) Binding Domain Does Not Mediate JAK3 Association or Activation in B-Lymphoma or Lymphoblastoid Cell Lines , 2002, Journal of Virology.

[271]  S. Goodbourn,et al.  The V Protein of Simian Virus 5 Inhibits Interferon Signalling by Targeting STAT1 for Proteasome-Mediated Degradation , 1999, Journal of Virology.

[272]  S. Majumder,et al.  p48/STAT-1alpha-containing complexes play a predominant role in induction of IFN-gamma-inducible protein, 10 kDa (IP-10) by IFN-gamma alone or in synergy with TNF-alpha. , 1998, Journal of Immunology.

[273]  Yue Wang,et al.  Mycobacteria inhibition of IFN-gamma induced HLA-DR gene expression by up-regulating histone deacetylation at the promoter region in human THP-1 monocytic cells. , 2005, Journal of immunology.

[274]  J E Darnell,et al.  A nuclear protein tyrosine phosphatase is required for the inactivation of Stat1. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[275]  B. Mach,et al.  Activation of the MHC class II transactivator CIITA by interferon-gamma requires cooperative interaction between Stat1 and USF-1. , 1998, Immunity.

[276]  M. Rowe,et al.  The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. , 1995, Oncogene.

[277]  N. S. Eyre,et al.  A screening method for identifying disruptions in interferon signaling reveals HCV NS3/4a disrupts Stat-1 phosphorylation. , 2008, Antiviral research.

[278]  D. Wesemann,et al.  STAT-1α and IFN-γ as Modulators of TNF-α Signaling in Macrophages: Regulation and Functional Implications of the TNF Receptor 1:STAT-1α Complex1 , 2003, The Journal of Immunology.

[279]  J. Darnell,et al.  Two contact regions between Stat1 and CBP/p300 in interferon γ signaling , 1996 .

[280]  Dan Yang,et al.  Cooperation of STAT-1 and IRF-1 in Interferon-γ-induced Transcription of the gp91 phox Gene* , 2002, The Journal of Biological Chemistry.

[281]  Paul Tempst,et al.  Regulation of p53 activity through lysine methylation , 2004, Nature.

[282]  P. Pitha,et al.  Retinoic acid resistance in NB4 APL cells is associated with lack of interferon α synthesis Stat1 and p48 induction , 1999, Oncogene.

[283]  A. Bardelli,et al.  Induction of epithelial tubules by growth factor HGF depends on the STAT pathway , 1998, Nature.

[284]  L. Kinnunen,et al.  Arginine/Lysine-rich Structural Element Is Involved in Interferon-induced Nuclear Import of STATs* , 2001, The Journal of Biological Chemistry.

[285]  J. Darnell,et al.  Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interactions , 1994, Cell.

[286]  J. Darnell,et al.  Interactions of alpha‐ and gamma‐interferon in the transcriptional regulation of the gene encoding a guanylate‐binding protein. , 1989, The EMBO journal.

[287]  L. Platanias,et al.  Signaling pathways activated by interferons. , 1999, Experimental hematology.

[288]  O. Colamonici,et al.  Direct binding to and tyrosine phosphorylation of the alpha subunit of the type I interferon receptor by p135tyk2 tyrosine kinase , 1994, Molecular and cellular biology.

[289]  G. Lenoir,et al.  Resistance to fludarabine-induced apoptosis in Epstein-Barr virus infected B cells , 2002, Oncogene.

[290]  James M. Roberts,et al.  CDK inhibitors: positive and negative regulators of G1-phase progression. , 1999, Genes & development.

[291]  T. Decker,et al.  Phosphorylation of the Stat1 transactivating domain is required for the response to type I interferons , 2003, EMBO reports.

[292]  T. Sugihara,et al.  TRAIL expression up-regulated by interferon-gamma via phosphorylation of STAT1 induces myeloma cell death. , 2006, Anticancer research.

[293]  D. Levy,et al.  Targeted Disruption of the Mouse Stat1 Gene Results in Compromised Innate Immunity to Viral Disease , 1996, Cell.

[294]  K. L. Fries,et al.  Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene , 1996, Journal of virology.

[295]  B. Chait,et al.  Requirement of Ca2+ and CaMKII for Stat1 Ser-727 phosphorylation in response to IFN-γ , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[296]  M. Olivier,et al.  Proteasome-mediated Degradation of STAT1α following Infection of Macrophages with Leishmania donovani* , 2005, Journal of Biological Chemistry.

[297]  A. Satoskar,et al.  Leishmania inhibits STAT1-mediated IFN-gamma signaling in macrophages: increased tyrosine phosphorylation of dominant negative STAT1beta by Leishmania mexicana. , 2005, International journal for parasitology.

[298]  V. Volchkov,et al.  Ebola Virus VP24 Binds Karyopherin α1 and Blocks STAT1 Nuclear Accumulation , 2006, Journal of Virology.

[299]  P. Cohen,et al.  Stress-induced phosphorylation of STAT1 at Ser727 requires p38 mitogen-activated protein kinase whereas IFN-gamma uses a different signaling pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[300]  C. Hunter,et al.  STAT1 Plays a Critical Role in the Regulation of Antimicrobial Effector Mechanisms, but Not in the Development of Th1-Type Responses during Toxoplasmosis1 , 2004, The Journal of Immunology.

[301]  G. Lesinski,et al.  The antitumor effects of IFN-alpha are abrogated in a STAT1-deficient mouse. , 2003, The Journal of clinical investigation.

[302]  J. Lacy,et al.  Transcriptional regulation of the human IgE receptor (Fc epsilon RII/CD23) by EBV. Identification of EBV-responsive regulatory elements in intron 1. , 1992, Journal of immunology.

[303]  J. Rutledge,et al.  Adenosine Blocks IFN-γ-Induced Phosphorylation of STAT1 on Serine 727 to Reduce Macrophage Activation1 , 2009, The Journal of Immunology.

[304]  N. Cooper,et al.  Plasmacytoid differentiation of Epstein-Barr virus-transformed B cells in vivo is associated with reduced expression of viral latent genes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[305]  U. Vinkemeier,et al.  Arginine Methylation of STAT1 A Reassessment , 2004, Cell.

[306]  E. Kieff,et al.  The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[307]  Steven M. Holland,et al.  Impairment of Mycobacterial But Not Viral Immunity by a Germline Human STAT1 Mutation , 2001, Science.

[308]  G. Lenoir,et al.  Gene Array Identification of Epstein Barr Virus-Regulated Cellular Genes in EBV-Converted Burkitt Lymphoma Cell Lines , 2002, Laboratory Investigation.

[309]  L. Ting,et al.  Mycobacterium tuberculosis inhibits IFN-gamma transcriptional responses without inhibiting activation of STAT1. , 1999, Journal of immunology.

[310]  C. Horvath,et al.  STAT Protein Interference and Suppression of Cytokine Signal Transduction by Measles Virus V Protein , 2003, Journal of Virology.

[311]  K. Schroder,et al.  Interferon-gamma: an overview of signals, mechanisms and functions. , 2004, Journal of leukocyte biology.

[312]  G. Bornkamm,et al.  Autoactivation of the Epstein-Barr Virus Oncogenic Protein LMP1 during Type II Latency through Opposite Roles of the NF-κB and JNK Signaling Pathways , 2006, Journal of Virology.

[313]  Xin-Yuan Fu,et al.  Cell Growth Arrest and Induction of Cyclin-Dependent Kinase Inhibitor p21WAF1/CIP1 Mediated by STAT1 , 1996, Science.

[314]  R. Cattaneo,et al.  Tyrosine 110 in the measles virus phosphoprotein is required to block STAT1 phosphorylation. , 2007, Virology.

[315]  C. Basler,et al.  Ebola Virus VP24 Proteins Inhibit the Interaction of NPI-1 Subfamily Karyopherin α Proteins with Activated STAT1 , 2007, Journal of Virology.

[316]  N. Gueven,et al.  The complexity of p53 stabilization and activation , 2006, Cell Death and Differentiation.

[317]  M. Urashima,et al.  Oncostatin M induces association of Grb2 with Janus kinase JAK2 in multiple myeloma cells , 1995, The Journal of experimental medicine.

[318]  A. Porras,et al.  p38 MAPK enhances STAT1-dependent transcription independently of Ser-727 phosphorylation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[319]  M. Oren,et al.  Mdm2 promotes the rapid degradation of p53 , 1997, Nature.

[320]  R. Gazzinelli,et al.  Replication of Toxoplasma gondii, but NotTrypanosoma cruzi, Is Regulated in Human Fibroblasts Activated with Gamma Interferon: Requirement of a Functional JAK/STAT Pathway , 1999, Infection and Immunity.

[321]  S. Kotenko,et al.  The expanded family of class II cytokines that share the IL‐10 receptor‐2 (IL‐10R2) chain , 2004, Journal of leukocyte biology.

[322]  M. Vaysberg,et al.  Activation of the JAK/STAT Pathway in Epstein Barr Virus+‐Associated Posttransplant Lymphoproliferative Disease: Role of Interferon‐γ , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[323]  Sami Al-Hajjar,et al.  Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency. , 2003, Nature genetics.

[324]  Ling He,et al.  Inhibition of the interferon-gamma/signal transducers and activators of transcription (STAT) pathway by hypermethylation at a STAT-binding site in the p21WAF1 promoter region. , 2000, Cancer research.

[325]  E. Coccia,et al.  Selective Expression of Type I IFN Genes in Human Dendritic Cells Infected with Mycobacterium tuberculosis1 , 2002, The Journal of Immunology.

[326]  E. Kieff,et al.  Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation , 1996, Molecular and cellular biology.

[327]  Michael Weiden,et al.  Inhibition of Response to Alpha Interferon by Mycobacterium tuberculosis , 2003, Infection and Immunity.

[328]  B. Stollar,et al.  Peripheral B cells latently infected with Epstein-Barr virus display molecular hallmarks of classical antigen-selected memory B cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[329]  P. Palese,et al.  Severe Acute Respiratory Syndrome Coronavirus Open Reading Frame (ORF) 3b, ORF 6, and Nucleocapsid Proteins Function as Interferon Antagonists , 2006, Journal of Virology.

[330]  L. Wong,et al.  IFN-gamma priming up-regulates IFN-stimulated gene factor 3 (ISGF3) components, augmenting responsiveness of IFN-resistant melanoma cells to type I IFNs. , 1998, Journal of immunology.

[331]  M. Ray,et al.  Inhibition of interferon-gamma signaling by Leishmania donovani. , 2000, The Journal of infectious diseases.

[332]  Mikhail Chernov,et al.  Regulation of c‐myc expression by IFN‐γ through Stat1‐dependent and ‐independent pathways , 2000 .

[333]  A. Jahnke,et al.  Synergistic activation of intercellular adhesion molecule 1 (ICAM‐1) by TNF‐α and IFN‐γ is mediated by p65/p50 and p65/c‐Rel and interferon‐responsive factor Statlα (p91) that can be activated by both IFN‐γ and IFN‐α , 1994 .

[334]  J. Darnell,et al.  Implications of an antiparallel dimeric structure of nonphosphorylated STAT1 for the activation-inactivation cycle. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[335]  V. Poli,et al.  IL-6, but not IFN-γ, triggers apoptosis and inhibits in vivo growth of human malignant T cells on STAT3 silencing , 2009, Leukemia.

[336]  C. Bucana,et al.  Stat1 negatively regulates angiogenesis, tumorigenicity and metastasis of tumor cells , 2002, Oncogene.

[337]  L. Yu-Lee,et al.  Sp1 is required for prolactin activation of the interferon regulatory factor-1 gene , 2001, Molecular and Cellular Endocrinology.

[338]  J. Dome,et al.  Serine-phosphorylated STAT1 is a prosurvival factor in Wilms' tumor pathogenesis , 2006, Oncogene.

[339]  C. Schindler,et al.  STATs Dimerize in the Absence of Phosphorylation* , 2003, Journal of Biological Chemistry.

[340]  Minoru Yoshida,et al.  CRM1 Is an Export Receptor for Leucine-Rich Nuclear Export Signals , 1997, Cell.

[341]  G. McFadden,et al.  Myxoma virus and Shope fibroma virus encode dual-specificity tyrosine/serine phosphatases which are essential for virus viability. , 1995, Virology.

[342]  James M. Roberts,et al.  The p21Cip1 and p27Kip1 CDK ‘inhibitors’ are essential activators of cyclin D‐dependent kinases in murine fibroblasts , 1999, The EMBO journal.

[343]  E. Kieff,et al.  Epstein–Barr virus latent membrane protein 1 activation of NF-κB through IRAK1 and TRAF6 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[344]  Yoichi Taya,et al.  DNA Damage-Induced Phosphorylation of p53 Alleviates Inhibition by MDM2 , 1997, Cell.

[345]  D. Wesemann,et al.  STAT-1 alpha and IFN-gamma as modulators of TNF-alpha signaling in macrophages: regulation and functional implications of the TNF receptor 1:STAT-1 alpha complex. , 2003, Journal of Immunology.

[346]  G. Stark,et al.  Defective TNF-alpha-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases. , 1997, Science.

[347]  S. Szabo,et al.  T-bet regulates IgG class switching and pathogenic autoantibody production , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[348]  W. Liu,et al.  Inhibition of STAT1 methylation is involved in the resistance of hepatitis B virus to Interferon alpha. , 2010, Antiviral research.

[349]  R. Knight,et al.  Induction of Apoptosis and Fas Receptor/Fas Ligand Expression by Ischemia/Reperfusion in Cardiac Myocytes Requires Serine 727 of the STAT-1 Transcription Factor but Not Tyrosine 701* , 2001, The Journal of Biological Chemistry.

[350]  M. Fellous,et al.  Interferon-α-dependent Activation of Tyk2 Requires Phosphorylation of Positive Regulatory Tyrosines by Another Kinase* , 1996, The Journal of Biological Chemistry.

[351]  Y. E. Chin,et al.  Stat1 as a Component of Tumor Necrosis Factor Alpha Receptor 1-TRADD Signaling Complex To Inhibit NF-κB Activation , 2000, Molecular and Cellular Biology.

[352]  A. Kentsis,et al.  Composition and Assembly of STAT-Targeting Ubiquitin Ligase Complexes: Paramyxovirus V Protein Carboxyl Terminus Is an Oligomerization Domain , 2005, Journal of Virology.

[353]  Oliver H. Krämer,et al.  Phosphorylation–acetylation switch in the regulation of STAT1 signaling , 2010, Molecular and Cellular Endocrinology.

[354]  M. Marrero,et al.  Angiotensin II signalling events mediated by tyrosine phosphorylation. , 1996, Cellular signalling.

[355]  R. Crystal,et al.  Resolution of Primary Severe Acute Respiratory Syndrome-Associated Coronavirus Infection Requires Stat1 , 2004, Journal of Virology.

[356]  J. Krolewski,et al.  Dimerization of a chimeric CD4-interferon-alpha receptor reconstitutes the signaling events preceding STAT phosphorylation. , 1996, Oncogene.

[357]  L. Staudt,et al.  c‐MYC activation impairs the NF‐κB and the interferon response: Implications for the pathogenesis of Burkitt's lymphoma , 2007, International journal of cancer.

[358]  Z. Wen,et al.  Stat1 serine phosphorylation occurs independently of tyrosine phosphorylation and requires an activated Jak2 kinase , 1997, Molecular and cellular biology.